inosine pranobex
PolandDrugs containing this active substance
-
It is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin.
Form: tablets
Active substance Dosage inosine pranobex 500 mg ATC: J05AX05
Manufacturer: Polfarmex S.A.
-
This is an antiviral and immune-supporting medication. It is used for the treatment of herpes on the lips and facial skin, and as a supportive treatment for immunocompromised individuals suffering from recurrent upper respiratory tract infections.
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
This is an antiviral and immune-supporting medication. It is used for the treatment of herpes of the lips and facial skin, and as a support for individuals with reduced immunity experiencing recurrent upper respiratory tract infections.
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: Pharmaceutical Works POLPHARMA S.A. Medana Branch in Sieradz
-
It is an antiviral and immune-supporting medicine. It is used for recurrent upper respiratory tract infections in individuals with reduced immunity and for the treatment of herpes of the lips and facial skin.
Form: syrup
Active substance Dosage inosine pranobex 250 mg/5 ml ATC: J05AX05
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
This is an antiviral and immune-supporting medicine. It is used for the treatment of herpes of the lips and facial skin, and as a supportive treatment in individuals with reduced immunity who suffer from recurrent upper respiratory tract infections.
Form: syrup
Active substance Dosage inosine pranobex 250 mg/5 ml ATC: J05AX05
Manufacturer: Pharmaceutical Works POLPHARMA S.A. Medana Branch in Sieradz
-
The medicine is used as a supportive treatment in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin caused by the herpes simplex virus.
Form: tablets
Active substance Dosage inosine pranobex 500 mg ATC: J05AX05
Manufacturer: Polfarmex S.A.
-
It is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: Polfarmex S.A.
-
It is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: tablets
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Polfarmex S.A.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals who have previously suffered from herpes simplex).
Form: syrup
Active substance Dosage inosine pranobex 50 mg/ml ATC: J05AX05
Manufacturer: Gedeon Richter Poland Sp. z o.o. Gedeon Richter Romania S.A.
-
The medicine is used in skin and mucous membrane infections caused by herpes viruses (labial or genital) and the varicella-zoster virus (chickenpox and shingles). It also helps in other viral infections and supports the treatment of immunocompromised individuals with recurrent upper respiratory tract infections.
Form: syrup
Active substance Dosage inosine pranobex 50 mg/ml ATC: J05AX05
Manufacturer: Gedeon Richter Poland Sp. z o.o. Gedeon Richter Romania S.A.
-
The medicinal product is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: solution for oral use, granules
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Gedeon Richter Polska Sp. z o.o.
-
The medicinal product is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously infected with the herpes simplex virus).
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: Gedeon Richter Poland Sp. z o.o. Gedeon Richter Romania S.A.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin caused by the herpes simplex virus.
Form: tablets
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Gedeon Richter Polska Sp. z o.o.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin in individuals previously diagnosed with herpes simplex virus infection.
Form: syrup
Active substance Dosage inosine pranobex 50 mg/ml ATC: J05AX05
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: tablets
Active substance Dosage inosine pranobex 500 mg ATC: J05AX05
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin.
Form: syrup
Active substance Dosage inosine pranobex 100 mg/ml ATC: J05AX05
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin.
Form: tablets
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Mako Pharma Sp. z o.o.
-
It is used in skin and mucous membrane infections caused by the herpes simplex virus (oral or genital) and the varicella-zoster virus (chickenpox and shingles). It is also helpful in other viral infections and as part of supportive treatment for individuals with impaired immunity.
Form: tablets
Active substance Dosage inosine pranobex 500 mg ATC: J05AX05
Manufacturer: Lusomedicamenta - Sociedade Técnica Farmacêutica S.A.
-
The medicine is used in infections of the skin and mucous membranes caused by the herpes virus (labial or genital) as well as the varicella-zoster virus (chickenpox and shingles). It also helps in other viral infections and as part of supportive treatment for individuals with impaired immunity.
Form: syrup
Active substance Dosage inosine pranobex 250 mg/5 ml ATC: J05AX05
Manufacturer: Lusomedicamenta - Sociedade Técnica Farmacêutica S.A.
-
The medicine is used in the case of viral infections of the skin and mucous membranes (e.g., herpes labialis or genital herpes, chickenpox, shingles), in other viral infections, and to support the treatment of individuals with reduced immunity.
Form: granules for oral solution, in sachet
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Lusomedicamenta Sociedade Técnica Farmacêutica S.A.
-
It is an antiviral and immune-supporting medication. It is used in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, as well as in the treatment of herpes of the lips and facial skin.
Form: syrup
Active substance Dosage inosine pranobex 250 mg ATC: J05AX05
Manufacturer: Aflofarm Farmacja Polska Limited
-
This is an antiviral and immune-supporting medication. It is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus).
Form: tablets
Active substance Dosage inosine pranobex 500 mg ATC: J05AX05
Manufacturer: Aflofarm Farmacja Polska Limited
-
The medicinal product is used in adults and children over 8 years of age to support immunocompromised individuals during recurrent upper respiratory tract infections, in the treatment of herpes of the lips and facial skin, and in conditions of increased zinc requirement.
Form: tablets
Active substance Dosage inosine pranobex 1000 mg zinc gluconate 43.56 mg ATC: J05AX05
Manufacturer: Aflofarm Farmacja Polska Limited
-
The medicinal product is used as a supportive treatment in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin.
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: Aflofarm Farmacja Polska Limited
-
This is an antiviral and immune-supporting medication. It is used in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, as well as in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus).
Form: tablets
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Aflofarm Farmacja Polska Limited
-
This is an antiviral and immune-supporting medication. It is used in individuals with reduced immunity in cases of recurrent upper respiratory tract infections.
Form: syrup
Active substance Dosage inosine pranobex No input provided ATC: J05AX05
Manufacturer: ABC Farmaceutici S.P.A.
-
The medicine is used as a supportive treatment in individuals with reduced immunity in cases of recurrent upper respiratory tract infections. It has antiviral properties and stimulates the immune system.
Form: syrup
Active substance Dosage inosine pranobex 50 mg/ml ATC: J05AX05
Manufacturer: Galena” Pharmaceutical Workers' Cooperative
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: syrup
Active substance Dosage inosine pranobex 100 mg/ml ATC: J05AX05
Manufacturer: Galena” Pharmaceutical Workers' Cooperative
-
This is an antiviral and immune-supporting medication. It is used in adults to support the body during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin.
Form: powder for preparation of oral solution in sachet
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: Adamed Pharma S.A. Hermes Arzneimittel GmbH - Division: Hermes Pharma GmbH
-
This is an antiviral and immune-supporting medication. It is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin.
Form: powder for preparation of oral suspension
Active substance Dosage inosine pranobex 312.5 mg/ml ATC: J05AX05
Manufacturer: Adamed Pharma S.A. Mako Pharma Sp. z o.o.
-
The medicinal product is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin caused by the herpes simplex virus.
Form: syrup
Active substance Dosage inosine pranobex 500 mg/5 ml ATC: J05AX05
Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise
-
The medicinal product is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).
Form: tablets
Active substance Dosage inosine pranobex 1000 mg ATC: J05AX05
Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise